Advanced Search
Contact | Corporate | Help

Daily news email for August 07, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
AiCuris Promising Drugs Against Herpes Simplex (AIC316) and Human Cytomegalovirus (Letermovir, ...

CEVEC Licenses its Proprietary Human Cell Lines to Paragon Bioservices, Inc.

Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled ...

2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma

 BioSpace
A Bankrupt KV Pharmaceutical Now Goes After Some States

Pfizer Inc. Dodges Claim for Another Bextra Payout

Saladax Biomedical Inc. (SBI) Enters into Master Collaboration Agreement With Bristol-Myers Squibb Company

Epilepsy Drug Reverses Memory Loss in Animal Model of Alzheimer's Disease, Gladstone Institute Study

Lying Less Linked to Better Health, University of Notre Dame Study

BioSpace - Breaking News
Start-up Innovimmune Biotherapeutics, Inc. Pursues Pharma Partners, Shuns VC's

Cellceutix Reports Its Very Novel Anti-Cancer Agent, Kevetrin, at Dana-Farber Cancer Institute for Start of Clinical Trials

Rexahn Pharmaceuticals, Inc. Completes Exploratory Phase I Clinical Study of RX-3117

TWi Pharmaceuticals, Inc. Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients With Type 2 Diabetes.

Astellas Pharma Inc.'s Subsidiary Shutting Down, 13 Scientists and Staff Affected

Biotech News - Business Wire
Quanterix Issued Key Patent for Simoa Technology

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Operating Room Basins

Fidelis Diagnostics Partners with Exalenz Bioscience to Add H. pylori Breath Testing Solutions to Its Portfolio of Services

Galectin Therapeutics Planning Clinical Trials for Early 2013 to Treat Fatty Liver Disease with Advanced Fibrosis After Recent FDA Meeting

Upgrade Autoimmune Diagnostic Testing Using Multiplex Technology

 Biotech News - PR Newswire
German-based Contract Research Organization Verum.de Opens US Office to Expand Clinical Study Services in Central and Eastern Europe for American Pharma and Biotech

Neodyne Biosciences Announces Positive Interim Randomized Control Trial Results for Embrace Advanced Scar Therapy, Demonstrating a Highly Significant Difference in Scar Appearance Compared to Standard-of-Care Treatment

OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer

MiMedx® Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial

Aeterna Zentaris Granted Patent in the U.S. for AEZS-130 as Diagnostic Test for Adult Growth Hormone Deficiency
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Bioethics Commission Readies Privacy Advice

Customized Therapy

Biorenewables Companies Make Headway

Globus Medical Prices IPO at $12 per Share

Bristol-Myers Bet on Hepatitis C Drug Takes Major Hit

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Cures AHEAD Golf Invitational Raises Over $120,000 to Benefit The Gateway for Cancer Research

COPD Foundation Announces Second Phase of Groundbreaking COPDGene Project, Praises the National Heart, Lung, and Blood Institute's Continued Funding

Research and Markets: Regurgitation Global Clinical Trials Review, H1, 2012

The Patient Recruiting AgencyTM Announces a Research Study for Female Patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

CPRIT's Governing Board Ratifies $114 Million in New Cancer Awards

 Clinical Trials - PR Newswire
Affinium Pharmaceuticals, Ltd., Announces Completion of Recruitment for Phase 2 Clinical Trial of AFN-1252 in Acute Bacterial Skin & Skin Structure Infections

Teen Trailblazer to Share his Journey to Visionary Innovation Changing the Shape of Cancer Diagnosis at GIL 2012: Silicon Valley

University Hospitals Case Medical Center to Study Stem Cell Therapy for Stroke Treatment

Northwestern Researchers Investigate Treatment for Tumor Cells in Spinal Fluid

American College of Surgeons and Tennessee Health Care Leaders Host Forum to Discuss New Model for Improving Quality and Reducing Health Care Costs

 CNN Top Stories
Sailor surprises daughter at karate

Google doodle lets you run the hurdles

Actor tweets pic of co-star's behind

Opinion: U.S. should act now on Syria

Iran: Syria part of 'axis of resistance'
Contract Pharma
PharmaNet/i3 Names HR VP

ILS Appoints Director of Genomics

Pfizer, Janssen Alzheimer Therapy Misses Endpoint

EMD Millipore, Julphar in Diabetes Pact

Theorem, Gallus in Services Partnership

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

 FDA News - Business Wire
Harvard Clinical Research Institute Successfully Completes Randomization in the DAPT Study

Toshiba Receives FDA Clearance for the Industry's First 16-Element MR Flex Coils

Navidea Biopharmaceuticals Announces Second Quarter 2012 Financial Results

Amneal Pharmaceuticals Bucks Trend and Adds U.S. Manufacturing Jobs with Major Expansion

PerkinElmer Announces Financial Results for the Second Quarter of 2012
FDA Press Releases
FDA approves first generic versions of Singulair to treat asthma, allergies

FDA approves Zaltrap for metastatic colorectal cancer

Food Safety Guides for Groups Most Vulnerable to Foodborne Illness Now Available

FDA warns consumers not to eat cantaloupes from Burch Equipment LLC of North Carolina

FDA approves Tudorza Pressair to treat chronic obstructive pulmonary disease

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

 FierceBiotech
Elan faces uncertain future after Alzheimer's drug crash

Bristol-Myers, others track tricky CGRP drug target to beat migraine

Pluristem soars after stem cell drug aids recovery of cancer patient

UPDATED: Pfizer, J&J kill PhIII program for key Alzheimer's drug

Pfizer, J&J kill PhIII program for key Alzheimer's drug

FierceBiotech IT
Timeline: Qsymia approval process

Accelrys keeps pace with 13% jump in revenue

Bayer boosts diabetes message with new blog

Accenture snaps up pharma software outfit Octagon

AstraZeneca adopts search engine for scientists

 FierceBiotech Research
Isis Pharmaceuticals' 'anti-sense' drug combats muscular dystrophy in mice

HIV viral fragment delivers promising acute liver failure treatment

Epilepsy drug boosts brain function in Alzheimer's preclinical tests

Isis Pharmaceuticals' 'anti-sense' drug combats muscular dystrophy mice

HIV viral fragment delivers promising acute liver-failure treatment

 FiercePharma
WSJ: Top FDA officials knew about email surveillance

Did Ranbaxy give up exclusivity on copycat Provigil

Pfizer, J&J give up the ghost on Alzheimer's drug

J&J faces new marketing probes as Risperdal settlement nears

Merck's Singulair surrenders to generics posse
FiercePharma Manufacturing
Drugmakers join effort to ferret out sport-enhancing ingredients

Teva's Provigil may be one Ranbaxy forfeited in consent decree

Amneal doubling U.S. capacity, to add 500 jobs

Manufacturing, pricing problems lead to K-V bankruptcy

Fuji buys DKSH Thailand plant for $53M

 FierceVaccines
CDC preps for emerging swine flu strain

FDA lifts hold on Allergy Therapeutics' grass pollen allergy vax

UPDATED: In U.K., Pneumovax trumps Pfizer's Prevnar 13

Alnylam gets $3.2M milestone from GSK for vax tech

Old whooping cough vax more effective than new one

 Health News - BizJournals.com
Strong turnout expected in Tuesday's primary in Washington state

NY Times names Regional Medical Center Bayonet Point in heart probe story

Check out tweets from KCBJ's health care reform panel

Large employers health care costs to rise 7%

Three habits that drive down productivity
Health News - CNBC
Alzheimer Drug Trial Fails to Show Improvement

Fewer U.S. students buy sodas, sports drinks still a problem-study

Pfizer pays $60M to settle bribery charges

Obesity drug developer Orexigen takes bigger loss

MannKind 2Q loss narrows on year-ago payment

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Alzheimer's Disease Antibody Bombs

Alzheimer Disease Antibody Bombs

Genta Pursues Liquidation

A Blow Against Biowarfare: Elusys Awarded $50.2M More for Inhalational Anthrax Treatment

Rat Studies Reveal Unexpected Autism Gene Function
Marketwire - Pharma and Biotech
ProMetic to Report Second Quarter 2012 Financial Results and Hold Conference Call/Webcast

ProMetic tiendra un appel confnce/webdiffusion pour ses rltats financiers du second trimestre de 2012

Biostem U.S., Corporation Appoints Marina Pizarro, M.D. to Scientific and Medical Board of Advisors (SAMBA)

Qualstar Announces End of Life for TLS-8000 and RLS-8000 Libraries

Drug Companies Are Teaming With Academic Medical Centers to Create New Medicines, According to Tufts Center for the Study of Drug Development

 MassBio News
State, Local and Industry Officials Join KeraFAST to Open New Headquarters in Boston, MA

MLSC 2012 Capital Program Announcement

2012 Tax Incentive Program Announcement

Q&A With Jonathan Thomas

Policy Update

 Medical Pharma - PR Newswire
Psychemedics Corporation Announces Record Revenues

Sensus Healthcare Announces the Sale of its SRT-100 Superficial Radiotherapy Unit to Hong Kong Sanatorium & Hospital in Hong Kong

Six in 10 adults now get physically active by walking

K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets

Ansell Announces Intention to Purchase Comasec SAS Business
National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

 Nature Biotechnology
Reply to In support of the European Union biosimilar framework

In support of the European Union biosimilar framework

It's the problem, stupid!

Adult stem cell therapies walk the line

Biotech weathers 2Q12 slump

 New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment
New York Times- Pharmaceuticals
Alzheimer’s Drug Trials Halted by Johnson & Johnson and Pfizer

Novartis and Penn Unite On Anticancer Approach

China Arrests 2,000 in Counterfeit Drug Crackdown

2,000 Arrested in China in Crackdown on Counterfeit Drugs

Bristol-Myers to Suspend Hepatitis C Drug Study

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
Resumen: Clinipace Worldwide celebra 20 años de servicio en Europa

Results of landmark SWITCH study published, showing that TB blood tests are cost saving for screening health care workers

WellPoint Offers Six Tips for the Traveling Boomer

Research and Markets: Chinese Market for Orthopedic Soft Tissue Repair & Sports Medicine(Executive Summary)

Pfizer Announces Resolutions with DOJ and SEC Related to Certain International Operations

 Pharma News - PharmiWeb
Soul Alive

Avalere Analysis: Iowa Seniors Face Estimated $30 Million 2013-14 Reduction in Medicare-Funded Nursing Home Care

CTIA-The Wireless Association® Statement on the GAO Report on Wireless Phone Safety

MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants

Minnesota Dentists Bringing Free Dental Care To Patients In Need In Minnesota August 17-18, 2012

 Pharma News - PR Newswire
Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY

Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012

Rigel Announces Second Quarter 2012 Financial Results

Mylan Launches Generic Version of Singulair® Tablets and Singulair® Chewable Tablets
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
Applied Marketing Science Names John Burns Account Executive

Biotech Science News Announces the Top 10 Pharmaceutical Leaders...

The 6th Annual Life Sciences BioConference Live Kicks off September...

University Hospitals Case Medical Center to Study Stem Cell Therapy...

Now Available: Lab Manager Magazine Brings Practical Business and...
PRWeb - Pharmaceuticals
Nucleus Medical Media Captures Its Third SIGGRAPH Nomination

2-Color Kinetic Live Content Imaging: Essen BioScience Launches New...

MediScripts Names Pharma Industry Expert Jim Pantaleo as Executive...

Intrinsic Imaging Undergoes Extensive FDA Audit - Receives Zero 483...

Budco to Appear at the Integrated Marketing Virtual Conference and...

 Scientific American
Avatar Officer Installed at Arizona-Mexico Border Station

NASA's Curiosity Rover Lands Safely on Mars

Can Facebook Show How to Reduce the Growing Energy Use of the Internet

Bites from Vampire Bats Might Protect People against Rabies

Major Breeder of Research Dogs Faces Closure

 Sports - ESPN Basketball
A dance that's often contentious rather than collaborative

NCAA Eligibility's judge and jury

NCAA increases eligibility standards

UCLA C Stover dismissed for academic reason

Calhoun likely to miss 2-3 months, expert says
Sports News - ESPN
NCAA, pro leagues sue N.J. over sports betting

Trojans RB Redd practices, starts 'new chapter'

Little ditty Mellencamp's son walks on at Duke

Sooners lose OL Evans to season-ending injury

Wisconsin RB Ball hopes to return for opener

 Xconomy Life Sciences
After Persevering for 22 Years, Peregrine Semiconductor Nears IPO

Atterocor Lands $16M Series A Round For Cancer Therapy

Mayo and Myriad: Can Two Patent Rulings Chill Innovation

Domain-Backed Adynxx Enters the Wide Open World of Pain Drug R&D

Innovimmune Pursues Pharma Partners, Shuns VCs

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012